Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Modulates the Human In Vivo Metabolism of Bradykinin
- 22 August 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (8) , 829-832
- https://doi.org/10.1161/01.cir.102.8.829
Abstract
Background—Bradykinin is a cardioprotective peptide metabolized by the angiotensin-converting enzyme (ACE). An insertion/deletion (I/D) polymorphism in the ACE gene determines plasma ACE levels. Th...Keywords
This publication has 8 references indexed in Scilit:
- The Angiotensin-Converting Enzyme Gene Polymorphism and Responses to Angiotensins and Bradykinin in the Human ForearmJournal of Cardiovascular Pharmacology, 2000
- ACE Insertion/Deletion Genotype Affects Bradykinin MetabolismJournal of Cardiovascular Pharmacology, 1998
- Polymorphism of the angiotensin-converting enzyme gene and cardiovascular diseaseJournal of Molecular Medicine, 1997
- Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory AttributesBlood, 1997
- Vasodilation in black Americans: Attenuated nitric oxide-mediated responses*Clinical Pharmacology & Therapeutics, 1997
- Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.Hypertension, 1994
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990